NCT05568524

Brief Summary

The main objectives of this study are to evaluate safety and chronic effects of a low-load resistance exercise intervention (elbow flexions and extensions, and knee extensions) with blood flow restriction in people with hemophilia on quality of life, pain, and on physical and neuromuscular function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 5, 2022

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 15, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

September 29, 2022

Last Update Submit

January 30, 2026

Conditions

Keywords

HemophiliaElectromyographyMuscle ActivityResistance Training

Outcome Measures

Primary Outcomes (4)

  • HDsEMG

    Change from baseline to the end of the intervention, and the change between the intervention group and the control group.

    Baseline and week 8.

  • Hand-held dynamometry (isometric elbow flexion/extension, knee extension)

    Change from baseline to the end of the intervention, and the change between the intervention group and the control group.

    Baseline and week 8.

  • Muscle ultrasound (muscle mass, assessment of possible bleedings)

    Change from baseline to the end of the intervention, and the change between the intervention group and the control group.

    Baseline and week 8.

  • Digital goniometry for active elbow and knee ROM

    Change from baseline to the end of the intervention, and the change between the intervention group and the control group.

    Baseline and week 8.

Secondary Outcomes (5)

  • Self-reported pain intensity (Visual Analogue Scale (VAS) Scale 0-10)

    Baseline and week 8.

  • Pressure pain thresholds (digital algometry)

    Baseline and week 8.

  • Haemophilia Activities List (HAL) questionnaire

    Baseline and week 8.

  • A36 haemophilia quality of life (Hemofilia-QoL) questionnaire

    Baseline and week 8.

  • Patient Global Impression of Change Scale (PGICS)

    Baseline and week 8.

Study Arms (2)

Control

ACTIVE COMPARATOR

The training program for the control group consists of a telerehabilitation with traditional moderate-to-high load (60%-80% 1RM) exercises (the same as the intervention group sans BFR), utilizing elastic bands. This program for the control group will be conducted in an in-home real-time audio and video style and supervised by a physiotherapist.

Other: Control

BFRT

EXPERIMENTAL

The BFR training program for the intervention group consists of elbow flexion and extension, and knee extension exercises performed with low load (elastic bands; equivalent to 30% 1RM) and concurrent BFR (upper limb 50% AOP; lower limb 60% AOP). Subjects will perform 4 sets (30, 15, 15 and 15 reps) of each exercise with 30 s rest between sets and 5-minute rest between exercises.

Other: BFRT

Interventions

BFRTOTHER

Low-load (30% 1RM) resistance exercise with blood flow restriction

BFRT
ControlOTHER

Moderate-to-high load (60%-80% 1RM) resistance exercise

Control

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosis of hemophilia A or B and undergoing prophylaxis;
  • willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations;
  • approval by their hematologist to participate in the exercise program;
  • age between 18 and 60 years;
  • informed consent signed.

You may not qualify if:

  • the inability to attend exercise sessions at least twice a week for 8 consecutive weeks;
  • non adherence to instruction on proper exercise technique;
  • surgical procedures performed 6 weeks prior to or during the exercise program; - participation in any other form of exercise, not previously done, during the study;
  • changes in medication during the study;
  • a major bleeding episode that posed a risk or prevented exercise;
  • another hemostatic defect;
  • need for major surgery;
  • withdrawal of informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Facultat de Fisioteràpia

Valencia, Valencia, 46010, Spain

Location

MeSH Terms

Conditions

Hemophilia A

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Sofía Pérez Alenda

    University of Valencia

    PRINCIPAL INVESTIGATOR
  • Joaquín Calatayud

    University of Valencia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dean of Faculty of Physiotherapy

Study Record Dates

First Submitted

September 29, 2022

First Posted

October 5, 2022

Study Start

January 15, 2024

Primary Completion

January 30, 2026

Study Completion

January 30, 2026

Last Updated

February 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations